IL103546A0 - Triazaspirodecanone-methylchromans,their preparation and pharmaceutical compositions containing them - Google Patents

Triazaspirodecanone-methylchromans,their preparation and pharmaceutical compositions containing them

Info

Publication number
IL103546A0
IL103546A0 IL103546A IL10354692A IL103546A0 IL 103546 A0 IL103546 A0 IL 103546A0 IL 103546 A IL103546 A IL 103546A IL 10354692 A IL10354692 A IL 10354692A IL 103546 A0 IL103546 A0 IL 103546A0
Authority
IL
Israel
Prior art keywords
methylchromans
triazaspirodecanone
preparation
pharmaceutical compositions
compositions containing
Prior art date
Application number
IL103546A
Other languages
English (en)
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of IL103546A0 publication Critical patent/IL103546A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10Spiro-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyrane Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
IL103546A 1991-10-28 1992-10-26 Triazaspirodecanone-methylchromans,their preparation and pharmaceutical compositions containing them IL103546A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4135473A DE4135473A1 (de) 1991-10-28 1991-10-28 Triazaspirodecanon-methylchromane

Publications (1)

Publication Number Publication Date
IL103546A0 true IL103546A0 (en) 1993-03-15

Family

ID=6443565

Family Applications (1)

Application Number Title Priority Date Filing Date
IL103546A IL103546A0 (en) 1991-10-28 1992-10-26 Triazaspirodecanone-methylchromans,their preparation and pharmaceutical compositions containing them

Country Status (19)

Country Link
US (1) US6060482A (xx)
EP (1) EP0539803B1 (xx)
JP (1) JP3257708B2 (xx)
KR (1) KR930007945A (xx)
AT (1) ATE175414T1 (xx)
AU (1) AU650792B2 (xx)
CA (1) CA2081256A1 (xx)
CZ (1) CZ322492A3 (xx)
DE (2) DE4135473A1 (xx)
DK (1) DK0539803T3 (xx)
ES (1) ES2125879T3 (xx)
FI (1) FI924848A (xx)
GR (1) GR3029450T3 (xx)
HU (1) HUT64068A (xx)
IL (1) IL103546A0 (xx)
MX (1) MX9205869A (xx)
NO (1) NO923974L (xx)
TW (1) TW208010B (xx)
ZA (1) ZA928290B (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19522088A1 (de) * 1995-06-19 1997-01-02 Bayer Ag Benzisothiazolyl-substituierte Aminomethylchromane
CA2226058C (en) * 1997-01-30 2008-01-29 F. Hoffmann-La Roche Ag 8-substituted-1,3,8-triaza-spiro[4.5]decan-4-one derivatives
JP3989247B2 (ja) * 1999-12-06 2007-10-10 ユーロ−セルティーク エス.エイ. ノシセプチン受容体親和性を有するトリアゾスピロ化合物
US20050014818A1 (en) * 2001-11-09 2005-01-20 Masaru Mitsuda Process for producing optically active chroman derivative and intermediate
US6995168B2 (en) 2002-05-31 2006-02-07 Euro-Celtique S.A. Triazaspiro compounds useful for treating or preventing pain
CN100402529C (zh) * 2002-09-09 2008-07-16 詹森药业有限公司 用于治疗orl-1受体介导疾病的羟基烷基取代的1,3,8-三氮杂螺[4,5]癸-4-酮衍生物
CA2542626A1 (en) * 2003-10-16 2005-04-21 William R. Collier Fluid level detector and alarm apparatus
US20060178390A1 (en) * 2004-08-02 2006-08-10 Alfonzo Jordan 1,3,8-Triazaspiro[4,5]decan-4-one derivatives useful for the treatment of ORL-1 receptor mediated disorders
WO2008067167A1 (en) * 2006-11-28 2008-06-05 Janssen Pharmaceutica N.V. Salts of 3-(3-amino-2-(r)-hydroxy-propyl)-1-(4-fluoro-phenyl)-8-(8-methyl-naphthalen-1-ylmethyl)-1,3,8-triaza-spiro[4.5]decan-4-one
WO2008124209A1 (en) * 2007-04-09 2008-10-16 Janssen Pharmaceutica, N.V. 1,3,8-trisubstituted-1,3,8-triaza-spiro[4.5]decan-4-one derivatives as ligands of the orl-i receptor for the treatment of anxiety and depression

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3826835A (en) * 1971-01-08 1974-07-30 Ciba Geigy Corp 8-benzofurylmethyl-1,3,8-triazaspiro(4,5)decanes as neuroleptics
US4826848A (en) * 1985-04-15 1989-05-02 Janssen Pharmaceutica N.V. Antidepressive substituted N-[(4-piperidinyl)alkyl] bicyclic condensed oxazol- and thiazolamines
US4689330A (en) * 1985-04-15 1987-08-25 Janssen Pharmaceutica N.V. Antidepressive substituted N-[(4-piperidinyl)alkyl] bicyclic condensed oxazol- and thiazolamines
US4749702A (en) * 1985-04-15 1988-06-07 Janssen Pharmaceutica N. V. Antidepressive substituted N-[(4-piperidinyl)alkyl] bicyclic condensed oxazol- and thiazolamines
US4957928A (en) * 1986-06-26 1990-09-18 Ciba-Geigy Corporation Hydrogenated 1-benzooxacycloalkylpyridinecarboxylic acid compounds
DE3901814A1 (de) * 1988-07-28 1990-02-01 Bayer Ag Substituierte aminomethylzetraline sowie ihre heterocyclischen analoga
DE3831888A1 (de) * 1988-09-20 1990-03-29 Troponwerke Gmbh & Co Kg Arzneimittel zur behandlung von apoplexia cerebri
DE4039631A1 (de) * 1990-12-12 1992-06-17 Troponwerke Gmbh & Co Kg Neuroprotektive kombination

Also Published As

Publication number Publication date
FI924848A0 (fi) 1992-10-26
JPH05222040A (ja) 1993-08-31
NO923974D0 (no) 1992-10-13
AU650792B2 (en) 1994-06-30
GR3029450T3 (en) 1999-05-28
HU9203382D0 (en) 1993-01-28
DE59209607D1 (de) 1999-02-18
ES2125879T3 (es) 1999-03-16
MX9205869A (es) 1993-04-01
TW208010B (xx) 1993-06-21
EP0539803B1 (de) 1999-01-07
DK0539803T3 (da) 1999-08-30
US6060482A (en) 2000-05-09
NO923974L (no) 1993-04-29
CA2081256A1 (en) 1993-04-29
KR930007945A (ko) 1993-05-20
EP0539803A1 (de) 1993-05-05
ATE175414T1 (de) 1999-01-15
JP3257708B2 (ja) 2002-02-18
ZA928290B (en) 1993-05-04
CZ322492A3 (en) 1993-07-14
HUT64068A (en) 1993-11-29
AU2626592A (en) 1993-04-29
DE4135473A1 (de) 1993-04-29
FI924848A (fi) 1993-04-29

Similar Documents

Publication Publication Date Title
AU645709B2 (en) New 2,4-thiazolidinedione compounds, process for preparing them and pharmaceutical compositions containing them
AU2125192A (en) New naphthylethlylureas and naphthylethylthioureas, process for the preparation thereof, and pharmaceutical compositions containing them
IL104006A (en) Azaheterocyclylmethyl-chromans their preparation and pharmaceutical compositions containing them
IL109578A (en) Nor-bile acid derivatives processes for their preparation and the use of these compounds as medicaments
AU673893B2 (en) New pyridothiadiazones, processes for their preparation and the pharmaceutical compositions which contain them
AU2067692A (en) New 5-isoquinolinesulfonamides process for preparing them and pharmaceutical compositions containing them
AU656466B2 (en) New benzimidazole compounds, a process for their preparation and pharmaceutical compositions containing them
IL103546A0 (en) Triazaspirodecanone-methylchromans,their preparation and pharmaceutical compositions containing them
AU642053B2 (en) Novel compounds of N-benzoylproline, process for their preparation and pharmaceutical compositions containing them
CA2090584A1 (fr) Steroides comportant en position 17 un radical methylene lactone, leur procede et des intermediaires de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant
EP0288758A3 (en) Dihydropyridinamides, process for their preparation and their use in medicines
AU4861693A (en) New chromene compounds having a triene side chain, process for the preparation thereof, and pharmaceutical compositions containing them
AU3559793A (en) New 3-aminochroman spiro compounds, processes for their preparation and pharmaceutical compositions containing them
EP0533516A3 (fr) Nouveaux composés amidiques des 1-(alcoxybenzyl) pipérazines, leurs procédés de préparation, et les compositions pharmaceutiques qui les contiennent
AU5971990A (en) Renin-inhibiting amino oligohydroxy derivatives
NO933465L (no) Legemidler inneholdende 1,5,6,7-tetrahydro-4-indazol-4-on-derivater, nye 1,5,6,7-tetrahydro-4-indazol-4-on-derivater, og fremgangsmåte for deres fremstilling